PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice

References

• de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13–27. doi:10.1038/nrgastro.2015.186. PMID:26627550
   PubMed Web of Science ®Google Scholar
• Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F. Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol. 2009;6:519–27. doi:10.1038/nrclinonc.2009.111. PMID:19636327
   PubMed Web of Science ®Google Scholar
• Janssen KP, el-Marjou F, Pinto D, Sastre X, Rouillard D, Fouquet C, Soussi T, Louvard D, Robine S. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology. 2002;123:492–504. doi:10.1053/gast.2002.34786. PMID:12145803
   PubMed Web of Science ®Google Scholar
• Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, Jung A, Arkan MC, Kirchner T, Greten FR. Ink4 a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010;18:135–46. doi:10.1016/j.ccr.2010.06.013. PMID:20708155
   PubMed Web of Science ®Google Scholar
• Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6. doi:10.1038/nm.3967. PMID:26457759
   PubMed Web of Science ®Google Scholar
• Peters JM, Shah YM, Gonzalez FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer. 2012;12:181–95. PMID:22318237
   PubMed Web of Science ®Google Scholar
• Bouguen G, Langlois A, Djouina M, Branche J, Koriche D, Dewaeles E, Mongy A, Auwerx J, Colombel JF, Desreumaux P. Intestinal steroidogenesis controls PPARgamma expression in the colon and is impaired during ulcerative colitis. Gut. 2015;64:901–10. doi:10.1136/gutjnl-2014-307618. PMID:25053717
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, Parmentier-Decrucq E, Dessein R, Merour E, Chavatte P. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A. 2010;107:8772–7. doi:10.1073/pnas.0905745107. PMID:20421464
   PubMed Web of Science ®Google Scholar
• Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750–61. doi:10.1038/nri3088. PMID:22025054
   PubMed Web of Science ®Google Scholar
• Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Beyer M, Mayer G. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med. 2009;206:2079–89. doi:10.1084/jem.20082771. PMID:19737866
   PubMed Web of Science ®Google Scholar
• Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012;486:549–53. doi:10.1038/nature11132. PMID:22722857
   PubMed Web of Science ®Google Scholar
• Luo C, Lim JH, Lee Y, Granter SR, Thomas A, Vazquez F, Widlund HR, Puigserver P. A PGC1alpha-mediated transcriptional axis suppresses melanoma metastasis. Nature. 2016;537:422–426. doi:10.1038/nature19347. PMID:27580028
   PubMed Web of Science ®Google Scholar
• Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M. The metabolic co-regulator PGC1alpha suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645–56. doi:10.1038/ncb3357. PMID:27214280
   PubMed Web of Science ®Google Scholar
• Geach T. NASH: Pioglitazone safe and effective for treating T2DM in patients with NASH. Nat Rev Endocrinol. 2016;12:498.
   Google Scholar
• Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R. Pioglitazone after ischemic stroke or Transient Ischemic attack. N Engl J Med. 2016;374:1321–31. doi:10.1056/NEJMoa1506930. PMID:26886418
   PubMed Web of Science ®Google Scholar
• Prost S, Relouzat F, Spentchian M, Ouzegdouh Y, Saliba J, Massonnet G, Beressi JP, Verhoeyen E, Raggueneau V, Maneglier B. Erosion of the chronic myeloid leukaemia stem cell pool by PPARgamma agonists. Nature. 2015;525:380–3. doi:10.1038/nature15248. PMID:26331539
   PubMed Web of Science ®Google Scholar
• Banks AS, McAllister FE, Camporez JP, Zushin PJ, Jurczak MJ, Laznik-Bogoslavski D, Shulman GI, Gygi SP, Spiegelman BM. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature. 2015;517:391–5. doi:10.1038/nature13887. PMID:25409143
   PubMed Web of Science ®Google Scholar
• Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012;60:3678–83. doi:10.3791/3678. PMID:22331082
   PubMedGoogle Scholar
• Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, Zeitz M, Siegmund B, Kühl AA. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7:4557–76. PMID:25197329
   PubMed Web of Science ®Google Scholar
• Friedrich T, Richter B, Gaiser T, Weiss C, Janssen KP, Einwächter H, Schmid RM, Ebert MP, Burgermeister E. Deficiency of caveolin-1 in Apc(min/+) mice promotes colorectal tumorigenesis. Carcinogenesis. 2013;34:2109–18. doi:10.1093/carcin/bgt142. PMID:23640045
   PubMed Web of Science ®Google Scholar
• Abal M, Obrador-Hevia A, Janssen KP, Casadome L, Menendez M, Carpentier S, Barillot E, Wagner M, Ansorge W, Moeslein G. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation. Gastroenterology. 2007;132:2448–58. doi:10.1053/j.gastro.2007.03.027. PMID:17570218
   PubMed Web of Science ®Google Scholar
• Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 2012;21:836–47. doi:10.1016/j.ccr.2012.04.024. PMID:22698407
   PubMed Web of Science ®Google Scholar
• Granville CA, Memmott RM, Balogh A, Mariotti J, Kawabata S, Han W, Lopiccolo J, Foley J, Liewehr DJ, Steinberg SM. A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One. 2009;4:e5061. doi:10.1371/journal.pone.0005061. PMID:19330036
   PubMed Web of Science ®Google Scholar
• Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut. 2006;55:1104–13. doi:10.1136/gut.2005.081745. PMID:16547072
   PubMed Web of Science ®Google Scholar
• Guri AJ, Mohapatra SK, Horne WT, 2nd, Hontecillas R, Bassaganya-Riera J. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol. 2010;10:60. doi:10.1186/1471-230X-10-60. PMID:20537136
   PubMed Web of Science ®Google Scholar
• Moran-Salvador E, Titos E, Rius B, González-Périz A, García-Alonso V, López-Vicario C, Miquel R, Barak Y, Arroyo V, Clària J. Cell-specific PPARgamma deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. J Hepatol. 2013;59:1045–53. doi:10.1016/j.jhep.2013.06.023. PMID:23831119
   PubMed Web of Science ®Google Scholar
• Malur A, McCoy AJ, Arce S, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. J Immunol. 2009;182:5816–22. doi:10.4049/jimmunol.0803504. PMID:19380830
   PubMed Web of Science ®Google Scholar
• Kriegl L, Vieth M, Kirchner T, Menssen A. Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer. Oncotarget. 2012;3:1182–93. doi:10.18632/oncotarget.628. PMID:23045412
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol. 2010;10:365–76. doi:10.1038/nri2748. PMID:20414208
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116–20. doi:10.1038/nature05894. PMID:17515919
   PubMed Web of Science ®Google Scholar
• Pello OM, De Pizzol M, Mirolo M, Soucek L, Zammataro L, Amabile A, Doni A, Nebuloni M, Swigart LB, Evan GI. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood. 2012;119:411–21. doi:10.1182/blood-2011-02-339911. PMID:22067385
   PubMed Web of Science ®Google Scholar
• Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 2012;7:e50946. doi:10.1371/journal.pone.0050946. PMID:23284651
   PubMed Web of Science ®Google Scholar
• Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S, Chen L, Toyoda S, Kirkner GJ, Wang YL. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology. 2009;136:1242–50. doi:10.1053/j.gastro.2008.12.048. PMID:19186181
   PubMed Web of Science ®Google Scholar
• Li H, Sorenson AL, Poczobutt J, Amin J, Joyal T, Sullivan T, Crossno JT Jr, Weiser-Evans MC, Nemenoff RA. Activation of PPARgamma in myeloid cells promotes lung cancer progression and metastasis. PLoS One. 2011;6:e28133. doi:10.1371/journal.pone.0028133. PMID:22145026
   PubMed Web of Science ®Google Scholar
• Avena P, Anselmo W, Whitaker-Menezes D, Wang C, Pestell RG, Lamb RS, Hulit J, Casaburi I, Andò S, Martinez-Outschoorn UE. Compartment-specific activation of PPARgamma governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle. 2013;12:1360–70. doi:10.4161/cc.24289. PMID:23574724
   PubMed Web of Science ®Google Scholar
• Bedi B, Yuan Z, Joo M, Zughaier SM, Goldberg JB, Arbiser JL, Hart CM, Sadikot RT. Enhanced clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated receptor Gamma. Infect Immun. 2016;84:1975–85. doi:10.1128/IAI.00164-16. PMID:27091928
   PubMed Web of Science ®Google Scholar
• Kogiso M, Shinohara T, Dorey CK, Shibata Y. Role of PPARgamma in COX-2 activation in mycobacterial pulmonary inflammation. Inflammation. 2012;35:1685–95. doi:10.1007/s10753-012-9486-x. PMID:22696146
   PubMed Web of Science ®Google Scholar
• Penas F, Mirkin GA, Vera M, Cevey Á, González CD, Gómez MI, Sales ME, Goren NB. Treatment in vitro with PPARalpha and PPARgamma ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice. Biochim Biophys Acta. 2015;1852:893–904. doi:10.1016/j.bbadis.2014.12.019. PMID:25557389
   PubMed Web of Science ®Google Scholar
• Lefevre L, Gales A, Olagnier D, Bernad J, Perez L, Burcelin R, Valentin A, Auwerx J, Pipy B, Coste A. PPARgamma ligands switched high fat diet-induced macrophage M2b polarization toward M2 a thereby improving intestinal Candida elimination. PLoS One. 2010;5:e12828. doi:10.1371/journal.pone.0012828. PMID:20877467
   PubMed Web of Science ®Google Scholar
• Serghides L, Kain KC. Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol. 2001;166:6742–8. doi:10.4049/jimmunol.166.11.6742. PMID:11359831
   PubMed Web of Science ®Google Scholar
• Diaz-Gandarilla JA, Osorio-Trujillo C, Hernandez-Ramirez VI, Talamás-Rohana P. PPAR activation induces M1 macrophage polarization via cPLA(2)-COX-2 inhibition, activating ROS production against Leishmania mexicana. Biomed Res Int. 2013;2013:215283. doi:10.1155/2013/215283. PMID:23555077
   PubMedGoogle Scholar
• Fernandez-Boyanapalli RF, Frasch SC, Thomas SM, Malcolm KC, Nicks M, Harbeck RJ, Jakubzick CV, Nemenoff R, Henson PM, Holland SM. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. J Allergy Clin Immunol. 2015;135:517–527 e12. doi:10.1016/j.jaci.2014.10.034. PMID:25498313
   PubMed Web of Science ®Google Scholar
• Van Ginderachter JA, Meerschaut S, Liu Y, Brys L, De Groeve K, Hassanzadeh Ghassabeh G, Raes G, De Baetselier P. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood. 2006;108:525–35. doi:10.1182/blood-2005-09-3777. PMID:16527895
   PubMed Web of Science ®Google Scholar
• Fernandez-Boyanapalli RF, Falcone EL, Zerbe CS, Marciano BE, Frasch SC, Henson PM, Holland SM, Bratton DL. Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment. J Allergy Clin Immunol. 2015;136:1399–401 e1-3. doi:10.1016/j.jaci.2015.07.034.
   PubMed Web of Science ®Google Scholar
• Wu L, Yan C, Czader M, Foreman O, Blum JS, Kapur R, Du H. Inhibition of PPARgamma in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis. Blood. 2012;119:115–26. doi:10.1182/blood-2011-06-363093. PMID:22053106
   PubMed Web of Science ®Google Scholar
• Karin N, Wildbaum G. The role of Chemokines in shaping the balance between CD4(+) T cell subsets and its Therapeutic implications in Autoimmune and cancer diseases. Front Immunol. 2015;6:609. doi:10.3389/fimmu.2015.00609. PMID:26648938
   PubMed Web of Science ®Google Scholar
• Dolgin E. Cancer immunology community seeks better end points. Nat Rev Drug Discov. 2016;15:807–809. doi:10.1038/nrd.2016.254. PMID:27895329
   PubMed Web of Science ®Google Scholar
• Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17:286–301. doi:10.1038/nrc.2017.17. PMID:28338065
   PubMed Web of Science ®Google Scholar
• He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A. 2003;100:15712–7. doi:10.1073/pnas.2536828100. PMID:14660788
   PubMed Web of Science ®Google Scholar
• el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, Robine S. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–93. doi:10.1002/gene.20042. PMID:15282745
   PubMed Web of Science ®Google Scholar
• Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8:265–77. doi:10.1023/A:1008942828960. PMID:10621974
   PubMed Web of Science ®Google Scholar
• Friedrich T, Sohn M, Gutting T, Janssen KP, Behrens HM, Röcken C, Ebert MPA, Burgermeister E. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer. EBioMedicine. 2016;8:159–72. doi:10.1016/j.ebiom.2016.05.003. PMID:27428427
   PubMed Web of Science ®Google Scholar